Metals likely to remain strong despite short-term dips: Rohit Srivastava
Indian stock markets are showing strong gains, led by the banking sector. Nifty remains above 25,900. Experts see continued momentum in banking, with NBFCs and PSU banks leading. Metals are also attractive for investors. Sector-specific rallies are driving market strength. Investors should watch key levels for Bank Nifty and Nifty.
IRB Infrastructure shares soar 7% on Rs 9,270 crore project win
IRB Infrastructure shares rose sharply on Monday after the company bagged NHAI’s Rs 9,270-crore TOT-17 project, its highest-valued 20-year monetisation award. The award covers 366 kilometres across the Lucknow–Ayodhya–Gorakhpur corridor on NH-27, along with a section of the Lucknow–Varanasi route on NH-731. The order win is being seen as a major boost to IRB’s portfolio, […]
Healthcare momentum strong, but selectivity key amid steep valuations: Nischal Maheshwari
Market expert Nischal Maheshwari shares insights on current market trends. He highlights growth companies and those ready for execution. Investors should be selective, especially in sectors with high valuations. Asian Paints is seen as a trading bounce. Healthcare offers earnings momentum but requires careful stock selection. Data centres present a nascent opportunity, with EPC contractors […]
World is entering a global reset fueled by innovation: Stephen Dover
The global economy is entering a new era of regional trade and advanced technology. Innovation is no longer confined to the West, with China and India emerging as key players. Despite recent foreign investor exits, India’s long-term structural story remains strong.
Gold, silver prices open lower on hawkish US Fed commentary. What should you do?
Gold and silver slipped on Monday as traders booked profits after a strong global rally and hawkish Fed comments dampened hopes of a December rate cut. On MCX, gold fell 0.34% to ₹1,23,141 per 10g, while silver dropped 0.5% to ₹1,55,232 amid lingering inflation concerns and cautious Fed signals on further easing.
Alembic Pharmaceuticals shares rise 2% after USFDA nod for key hypertension drug
On Monday, Alembic Pharmaceuticals saw a surge in its stock prices after the USFDA greenlit its Diltiazem Hydrochloride Tablets, a crucial treatment for high blood pressure and angina. This pivotal approval brings the company’s total USFDA ANDA approvals to an impressive 230, highlighting its strong position in the pharmaceutical market.
Gold firms as investors focus on US data for more Fed cues
Gold prices edged higher as investors awaited key U.S. economic data this week, including nonfarm payrolls, for clues on the Federal Reserve’s interest rate path. Traders are now pricing in a lower probability of a rate cut next month, while a firm dollar and subdued physical demand weighed on the precious metal.
Positive Breakout: These 11 stocks cross above their 200 DMAs
In the Nifty500 pack, 11 stocks’ closing prices crossed above their 200 DMA (Daily Moving Averages) on November 14, 2025, according to stockedge.com’s technical scan data. The 200-day daily moving average (DMA) is used by traders as a key indicator for determining the overall trend in a particular stock. As long as the stock is […]
Asian stocks have cautious start, Bitcoin in focus
Asian markets opened with caution. Investors await crucial US economic data. Uncertainty surrounds the US Federal Reserve’s next move. Japan and Australia saw slight dips. South Korea’s equities climbed. Bitcoin’s gains have largely vanished. Oil prices are down, while gold is up. This week promises significant market movements.
India Inc Q2 profit growth bounces into double digits
With momentum strengthening, overall profit growth for a sample of 2,857 companies accelerated to a six-quarter high of 15.2%, helped by a lower base of 4.1% in the year-ago quarter and a double-digit advance by select companies in sectors including automobiles, cement, capital goods and oil and gas.